The constantly evolving science and emerging study results focused on adjuvant therapies have drastically changed the treatment landscape for patients with melanoma. Along with targeted therapies, immunotherapies have also been used as adjuvant treatment strategies for metastatic melanoma patients. Importantly, these adjuvant therapies have made their way into the treatment landscape for patients with advanced melanoma, improving relapse-free survival (RFS) in many recent studies.

Learn more by clicking here.